# Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension

> **NCT01456286** · PHASE2,PHASE3 · COMPLETED · sponsor: **Fundacion Clinic per a la Recerca Biomédica** · enrollment: 42 (actual)

## Conditions studied

- Liver Cirrhosis
- Portal Hypertension

## Interventions

- **DRUG:** sapropterin

## Key facts

- **NCT ID:** NCT01456286
- **Lead sponsor:** Fundacion Clinic per a la Recerca Biomédica
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2013-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01456286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01456286, "Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01456286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*